The popularity of Sildenafil initially fueled a boom for major pharmaceutical companies, nevertheless recent developments present a murky scenario for shareholders. Off-patent alternatives are eating into revenue, and https://pennyogcg887780.blogrelation.com/47807953/viagra-and-the-pharmaceutical-industry-a-volatile-bet